Clinical study on the effect of electroacupuncture on scalp points on cognitive function in schizophrenia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200063225

Enrollment

Unknown

Registered

2022-09-01

Start date

2022-09-01

Completion date

Unknown

Last updated

2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

Control group:Olanzapine and sham electroacupuncture

Electroacupuncture group:Olanzapine and electroacupuncture

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Meet the ICD-10 diagnostic criteria for schizophrenia; 2. Aged 18-50 years; 3. The dose of antipsychotics has been stable in the past 3 months.

Exclusion criteria

Exclusion criteria: 1. Pregnancy, lactation; 2. MECT has been done within 6 months; 3. Substance dependence or other psychiatric comorbidities; 4. Brain organic disease; 5. Serious physical diseases such as heart disease; 6. Equipped with a pacemaker; 7. Comorbid epilepsy; 8. Hearing impairment.

Design outcomes

Primary

Measure	Time frame
MATRICS Consensus Cognitive Battery;Event-related potential;Near infrared spectroscopy detection;Magnetic resonance spectrum;	—

Countries

China

Contacts

Public ContactZhiyuan Huang

Xiamen Xianyue Hospital

awpxmcn@qq.com+86 13306025996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026